Pharma Journalist - Page 764 of 957 -

Cognizant Extends Gilead Partnership to Expand AI-Enabled DevOps

CSL, Alentis Partner on $1.55B Kidney and Liver Drug

Alector Licenses Parkinson’s Drug Program to Genentech for $1.27B

FDA and EMA Accept Regulatory Submissions for Review of Talazoparib

Chimerix Receives Orphan Drug Designation from the FDA for Brincidofovir for the Treatment of Smallpox

Ironwood Pharmaceuticals Announces FDA Orphan Drug Designation for Olinciguat for the Treatment of Sickle Cell Disease

BlackThorn Therapeutics Initiates Phase 1 Study of BTRX-335140, an Investigational Kappa Opioid Receptor (KOR) Antagonist

Chugai’s HEMLIBRA Receives Priority Review Status from FDA for Hemophilia A Without Inhibitors

Hookipa and Gilead Enter into a Collaboration and License Agreement to Develop Immunotherapies Against HIV and Hepatitis B

InflaRx Opens New Research Facility in Ann Arbor

Sensei Biotherapeutics Reports New Data from Phase 1 Clinical Trial of SNS-301

Internationally Recognised Biobanks Sign Up To 8th Annual BioBanking Conference

Virpax Pharmaceuticals Licenses Liposome Drug Delivery Technology From LipoCure